Dr. Sakoulas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2001 4th Ave
San Diego, CA 92101Phone+1 619-446-1727Fax+1 858-616-8090
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1999 - 2002- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1999
Harvard Medical SchoolClass of 1995
Certifications & Licensure
CA State Medical License 2007 - 2025
MA State Medical License 1997 - 2012
NY State Medical License 2002 - 2011
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Multi-omic signatures of host response associated with presence, type, and outcome of enterococcal bacteremia.Charlie Bayne, Dominic McGrosso, Concepcion Sanchez, Leigh-Ana Rossitto, Maxwell Patterson
Msystems. 2025-02-18 - Enhanced Killing of Methicillin-Resistant Staphylococcus aureus with Ceftaroline or Vancomycin in Combination with Carbapenems.Allen Jankeel, Gabriel Pérez-Parra, Anuj K Khetarpal, Ivan A Alvarado, Victor Nizet
The Journal of Infectious Diseases. 2025-01-08 - Antibiotic stewardship in the emergency department setting: Focus on oral antibiotic selection for adults with skin and soft tissue infections.Heather M Draper, Michael J Rybak, Kerry L LaPlante, Thomas Lodise, George Sakoulas
American Journal of Health-System Pharmacy. 2024-10-23
Authored Content
- Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
- Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
- Another Look at Antimicrobial Prophylaxis for Dental Procedures in Patients with Prosthetic Heart ValvesOctober 2017
Press Mentions
04 Dec COVID-19: IVIG Reduced Progression to Ventilator and Shortened Hospital Stays in Sicker PatientsDecember 4th, 2020- Octapharma USA Presents Results of Investigational Use of Octagam® 10% for Severe COVID-19 Patients at ASH Annual MeetingDecember 2nd, 2020
- Intravenous Immunoglobulin Significantly Reduces Respiratory Morbidity in COVID-19 Study Supported by OctapharmaSeptember 9th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
